2010 Annual Meeting | Case Studies: Adult Metabolic Disorders
06:45 PM - 10:00 PM |
Break
|
|
07:00 PM - 07:20 PM |
Overview of Energy Metabolism
Mark Tarnopolsky, MD, PhD, FRCP |
|
07:20 PM - 08:30 PM |
Mitochondrial Cytopathies and Case Reports/Discussion
Mark Tarnopolsky, MD, PhD, FRCP |
|
08:45 PM - 09:25 PM |
Fatty Acid Oxidation Defects and Cases/Discussion
Ingrid Tein, MD, FRCP |
|
09:25 PM - 10:00 PM |
Glycogen Storage Disease and Cases/Discussion
Mark Tarnopolsky, MD, PhD, FRCP |
Ingrid Tein, MD, FRCP | No disclosure on file |
Mark Tarnopolsky, MD, PhD, FRCP | Dr. Tarnopolsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Tarnopolsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reneo . Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Tarnopolsky has stock in Synaptive Medical. Dr. Tarnopolsky has stock in CloudDx. The institution of Dr. Tarnopolsky has received research support from Canadian Institute for Health Research. Dr. Tarnopolsky has received intellectual property interests from a discovery or technology relating to health care. |